MAGNESIUM CITRATE - CAP 100MG 100 MG — DIN 02201917
MAGNESIUM (MAGNESIUM CITRATE) : 100 MG · SISU INC. · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is MAGNESIUM CITRATE - CAP 100MG?
MAGNESIUM CITRATE - CAP 100MG 100 MG contains MAGNESIUM (MAGNESIUM CITRATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02201917, held by SISU INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Magnesium Citrate in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Magnesium Citrate, across 7 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| GAHLER ENTERPRISES LTD. | 1 | 0 | MAGNESIUM CITRATE CAP 150MG | No marketed DIN |
| PREFERRED NUTRITION INC. | 1 | 0 | MAGNESIUM 150 MG | No marketed DIN |
| REGIME INDUSTRIES LTD. | 1 | 0 | MAGNESIUM 150 MG | No marketed DIN |
| ROYAL BODYCARE CANADA INC. | 1 | 0 | MAGNESIUM TABLETS 200MG | No marketed DIN |
| SISU INC. | 1 | 0 | MAGNESIUM CITRATE - CAP 100MG | No marketed DIN |
| SWISS HERBAL REMEDIES LTD. | 1 | 0 | MAGNESIUM CITRATE CAPLET 300MG | No marketed DIN |
| WN PHARMACEUTICALS LTD. | 1 | 0 | MAGNESIUM CITRATE 150MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Magnesium Citrate |
|---|---|
| ATC code | A12CC04 |
| AHFS class | 88:29.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02201917 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2201917 |
| Brand name | MAGNESIUM CITRATE - CAP 100MG |
| Generic / active ingredient | MAGNESIUM (MAGNESIUM CITRATE) : 100 MG |
| Market authorization holder | SISU INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12CC04 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12CC |
| Current status | CANCELLED POST MARKET |
| Status date | 04-Aug-2009 |
| Original market date | 1997-02-25 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Magnesium Citrate in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 7 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| MAGNESIUM 150 MG | 150 MG | CAPSULE | REGIME INDUSTRIES LTD. | CANCELLED POST MARKET | 02245975 |
| MAGNESIUM 150 MG | 150 MG | CAPSULE | PREFERRED NUTRITION INC. | CANCELLED POST MARKET | 02248877 |
| MAGNESIUM CITRATE 150MG | 150 MG | CAPSULE | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 02243649 |
| MAGNESIUM CITRATE CAP 150MG | 150 MG | CAPSULE | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 01942115 |
| MAGNESIUM CITRATE CAPLET 300MG | 300 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 01900390 |
| MAGNESIUM TABLETS 200MG | 200 MG | TABLET | ROYAL BODYCARE CANADA INC. | CANCELLED POST MARKET | 02057506 |
2 · Same class — other molecules in ATC A12CC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Magnesium | CHELATED MAGNESIUM SUPPLEMENT - TAB 100MG · CHELATED MAGNESIUM TAB 125MG · F.M. FORMULA · MAGNESIUM · +6 more | 11 | 0 | Not in Canada |
| Magnesium Chloride | FORMULE 454 · MAGNESIUM CHLORIDE 606.5MG · MAGNESIUM LIQ 2.87MG/ML · MAGNESIUM SUPPLEMENT · +2 more | 7 | 0 | Not in Canada |
| Magnesium Citrate | MAGNESIUM 150 MG · MAGNESIUM CITRATE - CAP 100MG · MAGNESIUM CITRATE 150MG · MAGNESIUM CITRATE CAP 150MG · +2 more | 7 | 0 | Not in Canada |
| Magnesium (Different Salts In Combination) | ACTI MAG 250 CAPLET · MAGNESIUM CITRAMATE CAP · MAGNESIUM CITRATE · MAGNESIUM COMPLEX 250MG · +1 more | 5 | 0 | Not in Canada |
| Magnesium Oxide | MAGNESIUM OXIDE TAB 420MG · MAGNESIUM-TAB | 2 | 0 | Not in Canada |
| Magnesium Gluconate | MAGNESIUM LIQ 114MG/15ML | 1 | 0 | Not in Canada |
| Magnesium Sulphate | MAGNESIUM SULFATE INJ 50% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A12C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A12CX | Other Mineral Products | 75 | 5 |
| A12C | Other Mineral Supplements | 1 | 0 |
| A12CA | Sodium Chloride | 1 | 0 |
| A12CB | Zinc · Zinc (Different Salts In Combination) · Zinc Gluconate · Zinc Protein Complex · Zinc Sulphate | 58 | 0 |
| A12CD | Sodium Fluoride | 1 | 0 |
| A12CE | Selenium · Sodium Selenite | 19 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.